Spots Global Cancer Trial Database for atorvastatin
Every month we try and update this database with for atorvastatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Statin Therapy in Young Adult Survivors of Childhood Cancer | NCT01733953 | Cardiovascular ... Childhood ALL Childhood NHL | Atorvastatin Sugar Pill (Pla... | 18 Years - 39 Years | University of Minnesota | |
| STOP Heart Disease in Breast Cancer Survivors Trial | NCT02674204 | Breast Cancer Heart Disease Cardiotoxicity Myocardial Dysf... | Atorvastatin Placebo | 18 Years - | Cedars-Sinai Medical Center | |
| Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment | NCT03024684 | HepatoCellular ... | Atorvastatin Placebo Oral Ta... | 20 Years - 75 Years | Chiayi Christian Hospital | |
| Atorvastatin Before Prostatectomy and Prostate Cancer | NCT01821404 | Prostatic Neopl... | Atorvastatin Placebo | 40 Years - 80 Years | Tampere University Hospital | |
| Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI | NCT01605344 | Advanced Adenoc... | FOLFIRI. Atorvastatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study | NCT03186404 | Cancer Heart Failure Cardiotoxicity | Atorvastatin Placebo oral ta... | 18 Years - | University Health Network, Toronto | |
| A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium | NCT02767362 | Endometrial Can... | Atorvastatin | 18 Years - 75 Years | UNC Lineberger Comprehensive Cancer Center | |
| Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer | NCT03358017 | Triple Negative... | Zoledronate Atorvastatin 80... Standard neoadj... | 18 Years - | Mario Negri Institute for Pharmacological Research | |
| Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial | NCT02603328 | Cerebral Cavern... | Atorvastatin Placebo | 18 Years - 80 Years | University of Chicago | |
| Targeting the Hippo Transducer TAZ in Breast Cancer With Statins | NCT02416427 | Breast Neoplasm... | Atorvastatin | 18 Years - 75 Years | Regina Elena Cancer Institute | |
| Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma | NCT00185731 | Leukemia Lymphoma, Non-H... | Atorvastatin | 18 Years - | Stanford University | |
| Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study | NCT03186404 | Cancer Heart Failure Cardiotoxicity | Atorvastatin Placebo oral ta... | 18 Years - | University Health Network, Toronto | |
| Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT | NCT03066466 | Acute Myeloid L... Acute Lymphocyt... Myelodysplastic... | Atorvastatin Methotrexate Tacrolimus | 18 Years - 75 Years | Loyola University | |
| Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI | NCT01605344 | Advanced Adenoc... | FOLFIRI. Atorvastatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis | NCT02022293 | Nasopharyngeal ... Radiation Thera... | Atorvastatin Placebo | 40 Years - 65 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines) | NCT02943590 | Heart Failure | Placebo Atorvastatin | 18 Years - | Massachusetts General Hospital | |
| LIpitor and biGuanide to Androgen Delay Trial | NCT02497638 | Prostate Cancer | Metformin Atorvastatin Placebo (corres... Placebo (corres... | 18 Years - 80 Years | University Health Network, Toronto | |
| Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer | NCT04915183 | Hearing Loss Head and Neck C... | Placebo Atorvastatin | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial | NCT02603328 | Cerebral Cavern... | Atorvastatin Placebo | 18 Years - 80 Years | University of Chicago | |
| Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study | NCT03186404 | Cancer Heart Failure Cardiotoxicity | Atorvastatin Placebo oral ta... | 18 Years - | University Health Network, Toronto | |
| STOP Heart Disease in Breast Cancer Survivors Trial | NCT02674204 | Breast Cancer Heart Disease Cardiotoxicity Myocardial Dysf... | Atorvastatin Placebo | 18 Years - | Cedars-Sinai Medical Center | |
| A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies | NCT03560882 | Malignant Disea... Solid Tumor Acute Myeloid L... Myelodysplastic... Cancer Relapsed Hemato... | Atorvastatin | 18 Years - | University of Kansas Medical Center | |
| Atorvastatin Effect on Reduction of COPD Exacerbations | NCT04789057 | Copd COPD Exacerbati... Smoking Gene Expression Atorvastatin | Atorvastatin 40... Placebo | 40 Years - 99 Years | Medical University of Bialystok | |
| Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer | NCT03819101 | Prostate Cancer | Acetylsalicylic... Atorvastatin | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA Melanoma | NCT06157099 | Clinical Stage ... | Atorvastatin Placebo Adminis... Computed Tomogr... Magnetic Resona... Electronic Heal... | 18 Years - | OHSU Knight Cancer Institute | |
| Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer | NCT01980823 | Breast Cancer Breast Tumors Cancer of Breas... | Metformin Atorvastatin Breast surgery | 21 Years - | Columbia University | |
| LIpitor and biGuanide to Androgen Delay Trial | NCT02497638 | Prostate Cancer | Metformin Atorvastatin Placebo (corres... Placebo (corres... | 18 Years - 80 Years | University Health Network, Toronto | |
| Zoledronate With Atorvastatin in Renal Cell Carcinoma | NCT00490698 | Kidney Cancer Renal Cell Carc... | Zoledronate Atorvastatin | - | M.D. Anderson Cancer Center | |
| The Effect of Atorvastatin on Androgens, Glucose Metabolism and Inflammation in Polycystic Ovary Syndrome (PCOS) Women | NCT01072097 | Polycystic Ovar... | Atorvastatin Placebo | 30 Years - 50 Years | University of Oulu | |
| Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation | NCT01491958 | Acute Myelogeno... Acute Lymphocyt... Myelodysplastic... | atorvastatin Tacrolimus methotrexate | 18 Years - 75 Years | Ohio State University Comprehensive Cancer Center | |
| Measuring Oncological Value of Exercise and Statin | NCT05796973 | Prostate Cancer Breast Cancer Kidney Cancer Ovarian Cancer Metastatic Brea... Metastatic Kidn... Metastatic Rena... Metastatic Rena... Metastatic Pros... Metastatic Pros... Metastatic Ovar... Metastatic Ovar... | Guided physical... Atorvastatin Independent exe... | 18 Years - 99 Years | Tampere University Hospital | |
| Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT) | NCT01988571 | Breast Cancer Lymphoma | Atorvastatin Placebo | 21 Years - 100 Years | Wake Forest University Health Sciences | |
| Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) | NCT05483010 | Clonal Cytopeni... Myelodysplastic... | Atorvastatin Rosuvastatin | 18 Years - | Washington University School of Medicine | |
| Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis | NCT02022293 | Nasopharyngeal ... Radiation Thera... | Atorvastatin Placebo | 40 Years - 65 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) | NCT05483010 | Clonal Cytopeni... Myelodysplastic... | Atorvastatin Rosuvastatin | 18 Years - | Washington University School of Medicine | |
| Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer | NCT00816244 | Breast Cancer Postmenopausal | Atorvastatin | 18 Years - | Lund University Hospital | |
| Atorvastatin Before Prostatectomy and Prostate Cancer | NCT01821404 | Prostatic Neopl... | Atorvastatin Placebo | 40 Years - 80 Years | Tampere University Hospital | |
| STOP Heart Disease in Breast Cancer Survivors Trial | NCT02674204 | Breast Cancer Heart Disease Cardiotoxicity Myocardial Dysf... | Atorvastatin Placebo | 18 Years - | Cedars-Sinai Medical Center | |
| Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study | NCT03186404 | Cancer Heart Failure Cardiotoxicity | Atorvastatin Placebo oral ta... | 18 Years - | University Health Network, Toronto | |
| STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines) | NCT02943590 | Heart Failure | Placebo Atorvastatin | 18 Years - | Massachusetts General Hospital | |
| Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation | NCT01491958 | Acute Myelogeno... Acute Lymphocyt... Myelodysplastic... | atorvastatin Tacrolimus methotrexate | 18 Years - 75 Years | Ohio State University Comprehensive Cancer Center | |
| Zoledronate With Atorvastatin in Renal Cell Carcinoma | NCT00490698 | Kidney Cancer Renal Cell Carc... | Zoledronate Atorvastatin | - | M.D. Anderson Cancer Center | |
| Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer | NCT03819101 | Prostate Cancer | Acetylsalicylic... Atorvastatin | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE) | NCT02099123 | Independent Liv... Disability Free... Elderly Healthy | Atorvastatin Placebo (for At... | 70 Years - | Monash University | |
| Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma | NCT02029573 | Glioblastoma Mu... | Atorvastatin Temozolomide Radiotherapy | 18 Years - 70 Years | King Fahad Medical City | |
| Statins and Breast Cancer Biomarkers | NCT00914017 | Breast Cancer | Atorvastatin Placebo | 35 Years - 55 Years | University of Vermont | |
| Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer | NCT00816244 | Breast Cancer Postmenopausal | Atorvastatin | 18 Years - | Lund University Hospital | |
| A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium | NCT02767362 | Endometrial Can... | Atorvastatin | 18 Years - 75 Years | UNC Lineberger Comprehensive Cancer Center | |
| STOP Heart Disease in Breast Cancer Survivors Trial | NCT02674204 | Breast Cancer Heart Disease Cardiotoxicity Myocardial Dysf... | Atorvastatin Placebo | 18 Years - | Cedars-Sinai Medical Center | |
| The MASTER Study (MAmmary Cancer STatin ER Positive Study) | NCT04601116 | Breast Cancer F... Estrogen Recept... | Atorvastatin 80... Placebo oral ta... | 18 Years - | Aarhus University Hospital | |
| The MASTER Study (MAmmary Cancer STatin ER Positive Study) | NCT04601116 | Breast Cancer F... Estrogen Recept... | Atorvastatin 80... Placebo oral ta... | 18 Years - | Aarhus University Hospital | |
| Impact of Atorvastatin on Prostate Cancer Progression During ADT | NCT04026230 | Metastatic Pros... Recurrent Prost... | Atorvastatin 80... Placebo oral ca... | 18 Years - | Tampere University Hospital | |
| Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer | NCT03830164 | Male Erectile D... Prostate Adenoc... Erectile Dysfun... Impotence | Atorvastatin Pentoxifylline Vitamin E Compo... | 18 Years - | M.D. Anderson Cancer Center | |
| Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer | NCT03819101 | Prostate Cancer | Acetylsalicylic... Atorvastatin | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Targeting the Hippo Transducer TAZ in Breast Cancer With Statins | NCT02416427 | Breast Neoplasm... | Atorvastatin | 18 Years - 75 Years | Regina Elena Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
